DOCSLIB.ORG

Formula Index

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Formula Index Formula Index Page numbers in lightface refer to entries in Volumes I and 2; page numbers in boldface refer to entries in Volume 3. CS H 9 N02 S2 Abromine Cheiroline 284 C6 H 13 N03 CSHll N02 3: 4-Dihydroxy-2-piperine methanol Salicornine 1196 170 CS H 14 N 2 0 Fagomine 194 Arachine 167 Galegine 613 C6 H6 N2 0 2 C7 H 6 N 2 0 2-( 2-Cyan oeth y 1)-3 -iso x alin-5 -one Nudiflorine 1028 130 C7 H 7 N02 C6 H 7 N03 Trigonelline 1338 Gentianaine 624 C7 Hs N4 0 2 Gentiocrucine 626, 204 Theobromine 1322 C6 HSNI Theophylline 1323 N-Methylpyridinium iodine 302 C7 H 9 N 3 0 4 C6 H 9 NO Willardiine 1413 Guvacine 648 C7 H9 N3 S Isoguvacine 648 Zapotidine 436 C H NO 6 ll C7 H9 N4 0 2 Alkaloid CP-P 62 Isowillardiine 788 N-F ormylpiperidine 197 C7 H lO N4 0 2 C6 H 12 N 2 0 2 Lathyrine 826 Prurienine I 137 C7 H ll N02 C 6 H 13 N Arecaidine 168 N-Methylpiperidine 300 Guvacoline 649 (+)-a-Pipecoline 1108 C7 H 12 N 2 0 C6 H 13 NO N-Depropionylcorticasine 451 N-Methylpiperidine N-oxide 300 N orloline 1017 C6 H 13N02 C7 H13 NO 439 Bellaridine 197 Arecoline 169 C7 H 13 N02 1/3: 2/3--Epoxy-la-hydroxymethyl- Stachydrine 1260 8-pyrrolizidine 524 C7 H 13 N03 CS H 14 N 20 Betonicine 204 F estucine 575 Turicine 1349 Loline 855 C7 H 1S N CSH1SN 2: 6-Dimethylpiperidine 173 'Y-C oniceine 321 C7H17 NO CS H 15 NO Alkaloid AS-l 28 1/3-Hydroxymethyl-8H-/3 C7H 17 N03 pyrrolizidine 718 Acetylcholine 5 ( - )-Hygrine 72 7 C7H21 N20 Isopelletierine 769 Temuline 1292 Laburnine 820 CS H7 N02 (±)-Pelletierine 1088 Gentianadine 624 ( - )-Pelletierine 1089 Cs Hs N2 0 2 1/I-Pelletierine 1089 Ricinine 1179 Physoperuvine 339 CS H9 N02 Retronecanol 1172 Loroquine 858 Trachelantamidine 1333 CS H 9 N03 CS H 1S N02 I-Methyl-5-carbomethozy-a­ Dihydroxyheliotridane 478 pyridone 291 Dihydroxytropane 480 CSH9 NS02 3a: 6/3--Tropanediol 1343 3-(6-Amino-9-H-purin-9-yl)­ Turneforcidine 1350 propionic acid 72 CSH1SN02S2 CS H lON 204 Gerrardoline 633 Leucaenine 841 CS H 1S N03 Mimosine 966 3 :4: 5-Trihydroxyoctahydro-l­ CSH lON402 pyrindine 1338 Caffeine 234 CS H16 N02 CsHn N Stachydrine ethyl ester 1260 Alkaloid V A-A 118 CSH16N202 Nicotoine 1003 Prurienine 1137 CSH12_14N2 CS H17N Alkaloid HE-A 80 (+)-Coniine 321 CS H13 N (-)-1: 2 :6-Trimethylpiperidine I-Methylenepyrrolizidine 947 410 CS H 13 NO CSH17NO 7a-Hydroxy-l-methylene-8/3- Conhydrine 320 pyrrolizidine 717 a-Conhydrine 320 CSH 13N02 Hygroline 728 Arecolidine 169 Sedridine 1216 440 C9HSN2 4-Methoxy-a-hydroxy-l3- 4-Methyl-2:6-naphthyridine 955 phenethylamine 929 C9 HSN2 0 C9 H 13 N4 0 4 Glycorine 639 Eritadenine 535 C9HSN 202 C9H,sNO Glycosmicine 640 1-Methoxymethyl-l : 2-dehydro- C9 H9 N02 8a-pyrrolizidine 931 Gentianidine 624 C9H,sN02 3-Methoxycarbonyl-5-vinylpyridine Chysine A 292 923 113,213-Epoxy-l-a-methoxymethyl- Resedine 357 8-a-pyrrolizidine 525 C9H lON2 7-Hydroxy-l-methoxymethyl-l : 2- Myosmine 982 dehydro-8-pyrrolizidine 715 C9HllN 7a-Hydroxy-l-methoxymethyl- N oractinidine 314 1: 2-dehydro-8-a-pyrrolizidine 715 C9 H U NO Alkaloid LP-A 51 (+ )-l-(methoxycarbonyl) 6: 7 -Dihydro-6-hydroxy-7 -methyl- pyrrolizidine 922 5H-2-pyridine 469 C9 H,6NO Gentialutine 203 (+ )-Aza-I-methylbicyclo [3,3,1)- Isogentialutine 244 nonan-3-one 189 Leptorhabine 263 C9H,7NO Methylisopelletierine 951 C9Hll N02 Alkaloid CA-A 32 N-Methy1pelletierine 957 Alkaloid GT-A 79 C9H'9 N Gentiatibetine 204 N-Methyl-( + )-coniine 941 C9Hll N03 N-Methyl-( - )-coniine 941 Geoffroyine 626 C9H,9NO C9Hll N3 0 (+ )-Methylallosedridine 936 N-Nitrosonornicotine 314 C9H20N404 C9Hll Ns0 3 Alkaloid EF-A 44 Deoxyeritadenine 156 ClO HSN2 C9 H'2 N2 Nicotelline 1001 (+ )-N ornicotine 1019 ClO H9NO (-)-Nornicotine 1020 Echinopsine 502 C9 H 13 N Pediculidine 1083 N-Methyl-l3-phenethylamine 958 C lO H9 N02 C9 H 13 NO Gentianine 625 Halostachine 654 C lO H9 N03 N-Methyltyramine 964 N oroxyhydrastinine 1021 (-)-Norephedrine 1013 Siam in 373 (+)-Nor-l/I-ephedrine 1014 1: 2: 3 :4-Tetrahydro-6 ;7- C9 H 13 N02 methylenedioxy-l- 441 oxoisoquinoline 393 Tecostidine 1290 CIOHIONO C lO H 13 N02 Pediculine 1084 Longimammamine 267 ClOH lON20 Oliveri dine 1041 Nicotyrine 1004 C lO H13 N03 ClO H lON 20 Damascenine 389 Glomerine 638 ClO H13 NS ClOHllNO Triacanthine 1335 Boschniakine 212 ClOH14N2 Indicaine 740 Anabasine 143 Pedicularidine 1083 Nicotimine 1002 ClOHll N02 Nicotine 1002 Cantleyine 249 ClO H 14 N2 0 Pediculerine 1083 Cis-Nicotine-I' -N-oxide 313 Plan tagonine 1113, 341 Trans-Nictine-I' -N-oxide 313 ( - )-Plantagonine 341 ClOH14N203 Thesinisine 403 Damascinine 389 ClOHll N03 Pilocarpidine 1105 Alkaloid G-II1 44 ClOH1SN Gentioflavine 626 3: 4: 5: 6-Tetrahydro-2-(pentadienyl) ClOHll N04 pyridine 393 I: 2: 3:4-Tetrahydro6: 7- ClOH1SNO dihydroxyisoquinoline-3- Anhalinine 153 carboxylic acid 390 Ephedrine 5 18 ClOH12N2 Hordenine 696 (-)-Anatabine 147 Jaksartinine 252 (±)-Anatabine 147 Logimammine 268 Isonicoteine 768 N-Methyl-4-methoxyphenethyla- C lO H 12 N 2 0 mine 953 4-Aminoquinoline methohydroxide (+ )-Pseudoephedrine 349 72 C lO H 1S N02 Serotonine 371 3 :4-Dimethoxyphenethylamine ClO H 12 N 4 0 3 483 Alkaloid AL-A 45 {3-0-Methylsynephrine 961 ClO H 12 N 4 0 4 C lO H 1S N03 Nebularine 992 3-Demethylmescaline 153 ClO H13 N ClOH16 N2 Actinidine 19 Convolvicine 326 ClO H 13 NO Hystrine 734 Longimammadine 267 C lO H 16 N2 0 Longimammidine 268 Smipine 374 Longimammosine 268 ClOH16N202 Pediculinine 1084 Decorticasine 405 442 Lolinine 856 Robustinine 359 Lepistine 263 Cll H 12 Nd C lO H17 N02 I: 2-Dimethylquinol-4-one 488 3~-Acetoxytropane 4 Echinorine 502 Acetyllaburnine 10 Cll H12N2 Chysine B 293 Deoxypeganine 157 C lO H 17 N03 Cll H 12 N2O 30i.-Acetyl-6~-hydroxytropane 7 Alkaloid OS-I 52 ClO H 17 N 3 0 Homoglomerine 694 Dolichotheline 494 Peganol 1086 ClOH17N704 Plectocomine IllS Saxitoxin 365 Vasicine 1367 ClOH18N202 Cll H 12 N20 2 Alkaloid RL-A 105 Pegamine 1085 Siaframine 1234 Cll H 12 N20 3 ClOH19 N Jasminine 795 Dendroprimine 443 Cll H 13 NO Nor-N-methylskytanthine 316 Alkaloid GI-A 45 Saurenine 1206 3: 6: 6:-Trimethyl-5: 6-dihydro-7H- C lO H 19 NO 2-pyrindin-7 -one 410 Lupinine 866 C ll H 13 N02 Nitramine 1006 Echinine 176 Tetralupine 1302 N-2-Hydroxyethylcinnamide Virgilidine 1398 709 4-Methoxy-I-methyl-2-quinolone ClOH21 NO Halosaline 654 931 C H N0 ClOH22N4 ll 13 3 Sphaerophysine 1255 Alkaloid J-I 48 Alkaloid PF-I 53 C ll H9 N03 Anibine ISS Cantleyine 100 5: 6-Dihydro-6-hydroxy-6- Cll HlON2 5-Methyl-2: 3'-bipyridine 938 methoxycarbonyl-7-methyl-7H­ cyc10pentapyridine 468 Cll H lON 2 0 Deoxyvasicinone 449 Gentianamine 204 Thalifoline 399 CllH lON 2 0 2 Alkaloid OS-2 52 Cll H 13 N sOBr2 Vasicinone 1367 Dibromophakellin 455 (±)-Vasicinone 419 C ll H 14 N2 Cll Hll N03 Dipterine 491 Doryphornine 175 Gramine 642 Edulitine 507 (-)-N-Methylanatabine 936 Folifidine 585 Cll H 14 N2 0 Gentianamine 203 Cytisine 388 443 Cll H 1S NO Cll HlSN2 Valerianine 1364 Daucine 396 C ll H 15 N02 CnHlsN202 Bractamine 92 N-Depropionylcorticasine Corypalline 341 butyramide 451 Salsoline 1198 N -Depropionylcorticasine (+ )-Salsoline 363 isobutyramide 452 (±)-Salsoline 363 Cll H19 N s C ll H 1S N03 Do -Dehydroskytanthine 417 Alkaloid AL-I 21 C ll H 19 N02 Anhalamine 152 Tropine propionate 414 C ll H 1S N04 C ll H 19 N02 S4 N-Formylnormacromerine 591 Gerrardine 632 Cll H16 N2 Cll H21 N (-)-N-Methylanabasine 936 a-Skytanthine 1232 !3-Skytanthine 1232 C n H 16 N 2 0 2 Isopilocarpine 772 'Y-Skytanthine 1233 Pilocarpine 1105 o-Skytanthine 1233 !Ji-Pilocarpine 1106 Cll H21 NO 4(a)-Hydroxyskytanthine 721 Cll H16 N S Br 4-Bromophakellin 213 7(a)-Hydroxyskytanthine 231 C llH 17 NO Hydroxyskytanthine I 722 N-Methylephedrine 947 Hydroxyskytanthine II 722 (+)-N-Methyl-!Ji-ephedrine 947 /3-Skytanthine N-oxide 1233 O-Methylhordenine 951 Tecostanine 1290 Tecomanine 1289 Cll H21 N3 Pterogynidine 1145 Cn H 17 N02 Andrachnine 149 Pterogynine 1145 N-Methyl-3: 4-dimthoxy-/3- Cll H21 N30 3 phenethylamine 945 Shaksine 279 C ll H 17 N03 Isochaksine 752 7-/3-Acetoxy-methoxymethyl-l: 2- C 12 HsN 2 0 dehydro-8a-pyrrolizidine 3 Perlolidine 1095 N ormacromerine 1017 C 12 H9 N02 Tetrahydrocantleyine 389 Dictamnine 459 CllH 17 N/ C 12 H9 N03 Di( tetrahydropyridoimidazolinium) Confusameline 118 493 7-Hydroxy-4-methoxyfuro 2,3-b Cll H 17N 3 0 quinoline 714 Alchornine 42 Robustine 358 Arenaine 82 C 12 H9 N 3 N ormacrorine 1018 Cn H 1S NO Candicine 247 C 12 H lON2 444 Alkaloid PI-I 102 Alkaloid AL-III 22 Harmanine 212 Anhalonine 154 C l2 H lO N 2 0 6a,7-Didehydroaporheine 461 Harman 659 Hydrocotarnine 702 I-Hydroxymethyl-J3-carboline 717 N-MethYlcorydaldine 941 C l2 H l1 N04 Cl2H1SN04 Casimiroine 260 Alkaloid AL-VI 22 C l2 H 12 N2 Thalidaldine 399 Dihydroharman 165 C12 H I6 NO+ C 12 H 12 N 2 0 Indicainine 740 Harmalol 659 C 12 H16 N2 6: 7: 8: 9-Tetrahydropyrido 2,I-b Dimethyltryptamine 489 quinazolin-II-one 1300 C 12 H I6 N 2 0 C 12 H 13 N02 Bufotenine 217 Alkaloid PN-A 103 Caulophylline 269 Shihunine 1226 I: 5-Dimethoxy-(3-dimthyla- C 12 H 13 N03 minomethyl)indole 171 F olimine 196 5-Methoxy-N-methyltryptamine C 12 H 13 N04 931 Halfordamine 652 Methylcytisine 943 Thalflavine 1305, 396 C 12 H I7 N C12 H I4 N2 Nigrafactine 1004 Alkaloid GPZ-2 79 C 12 H n N02 Calligonine 242 O-Methylcorypalline 942 Eleagnine 5 12 N-Methyl-6: 7 -dimethoxytetrahydro- 2-Methyltetrahydro-J3-carboline isoquinolone 945 961 N-Methylisosalsoline 297 Tetrahydroharman 1296 ( - )-Salsolidine 1197 6: 7: 8: 9-Tetrahydro-11 H-pyrido (+ )-Salsolidine 1197 2,3-b quinazoline 1299 C 12 H 17 N03 C 12 H I4N 2 0 Alkaloid AL-II 21 N-Acetyltryptamine 9 Anhalidine IS 2 Calligonidine 98 Anhalinine IS 3 Dehydrobufotenine 407 Anhalonidine IS 3 Shepherdine 1226 Calycotomine
Load more

Recommended publications
  • Psychedelic Resource List.Pdf
    A Note from the Author… The Psychedelic Resource List (PRL) was born in 1994 as a subscription-based newsletter. In 1996, everything that had previously been published, along with a bounty of new material, was updated and compiled into a book. From 1996 until 2004, several new editions of the book were produced. With each new version, a decrease in font size correlated to an increase in information. The task of revising the book grew continually larger. Two attempts to create an updated fifth edition both fizzled out. I finally accepted that keeping on top of all of the new books, businesses, and organizations, had become a more formidable challenge than I wished to take on. In any case, these days folks can find much of what they are looking for by simply using an Internet search engine. Even though much of the PRL is now extremely dated, it occurred to me that there are two reasons why making it available on the web might be of value. First, despite the fact that a good deal of the book’s content describes things that are no longer extant, certainly some of the content relates to writings that are still available and businesses or organizations that are still in operation. The opinions expressed regarding such literature and groups may remain helpful for those who are attempting to navigate the field for solid resources, or who need some guidance regarding what’s best to avoid. Second, the book acts as a snapshot of underground culture at a particular point in history. As such, it may be found to be an enjoyable glimpse of the psychedelic scene during the late 1990s and early 2000s.
    [Show full text]
  • Download Book Sacred Journeys As
    Sa cred Jour neys: ©2015, 2016, 2017 Artscience Im ages: authors and friends, com pany and press pic- tures, PhotoDisc, Corel, Wikipedia, Mindlift Beeldbankiers. Dis tri bu tion: Boekencoöperatie Nederland u.a. email: [email protected] www.boekcoop.nl www.boekenroute.nl (webshop) All rights re served, in clud ing dig i tal re dis tri bu tion and ebook First editiion: De cem ber 2015, Sec ond, ap pended edition April 2016 Third edition Jan. 2017 ISBN 9789492079091 pub lisher: Onderstroomboven Collectief im print: Artscience. Pa perback price € 6,95 Con tents 1 Pre fa ce 7 2 Tripping: the process 10 Journey to the dream 10 The pre pa ra ti on 11 Pha ses, gig gling 13 Iso la ti on, li mi na li ty, the dark 14 Peak 19 Sit ters: de sig na ted hel pers 22 The mys ti cal, re gres si on 26 Rebirth and de ath 27 The end of the trip: co ming down 28 Over sti mu la ti on 29 The af ter-ef fects 30 3 Set and Set ting 32 Agen da 33 Pla ce 34 With whom, with what? 34 Bon ding and trans fe ren ce 35 Dif fe rent ways of using 36 4 Pur po se 37 Dee per goals 38 Over co ming fear 40 To le ran ce 41 5 Ri tu als and Group ses sions 42 He a ling jour neys, mys ti cal in sights 44 Me di cal use 45 Re pe ti ti on, loops 46 Stages of a ritu al 49 Ri tes of pas sa ge: ini ti a ti on 50 Contact – alignment - group mind 52 Struc tu re amidst cha os 54 To copy an existing ritu al or to crea te somet hing new 54 6 Sanc tu a ry, safe spa ce 57 Sa fe ty first 57 Sa cred spa ce, tem po ra ry au to no mous zone 58 Hol ding spa ce and cir cle in te gri ty 61 7 His to ry
    [Show full text]
  • D. M. Turner - Table of Contents
    Sssshhhh!! Don't blow our Cover!! file:///C|/Documents%20and%20Settings/All%20Users/Docume...r%20-%20the%20essential%20psychedelic%20guide/cover.html4/14/2004 9:40:08 PM D. M. Turner - Table of Contents TABLE OF CONTENTS Publication Information Foreword to the HTML Edition - by Forbidden Donut Introduction A Brief History of Psychedelics - From the Creation of Gods to the Demise of Psychedelic Reverence in Modern Times Psychedelic Safety - Understanding the Tools I - Traditional Psychedelics LSD - Molecule of Perfection Psilocybin Mushrooms - The Extraterrestrial Infiltration of Earth? Mescaline: Peyote & San Pedro Cactus - Shamanic Sacraments II - Empathogens Ecstasy - The Heart Opening Psychedelic 2C-B - The Erotic Empathogen III - Exotic Highs of a Connoisseur DMT - Candy for the Mind file:///C|/Documents%20and%20Settings/All%20Users/Doc...%20-%20the%20essential%20psychedelic%20guide/toc.html (1 of 2)4/14/2004 9:40:34 PM D. M. Turner - Table of Contents Harmala Alkaloids - Link to the Ancient Spirits Ketamine - The Ultimate Psychedelic Journey Multiple Combinations - Cosmic Synergism Further Explorations - Where do we go from Here? DMT ~ Water Spirit - A Magical Link Psychedelic Reality - CydelikSpace Bibliography Purchasing The Essential Psychedelic Guide Back Cover Text file:///C|/Documents%20and%20Settings/All%20Users/Doc...%20-%20the%20essential%20psychedelic%20guide/toc.html (2 of 2)4/14/2004 9:40:34 PM D. M. Turner - Publication Information The Essential Psychedelic Guide - By D. M. Turner First Printing - September 1994 Copyright ©1994 by Panther Press ISBN 0-9642636-1-0 Library of Congress Catalog registration in progress Printed in the United States of America Cover art by Nick Philip, SFX Lab Illustrations on pages 31, 41, 45, and 59 by P.B.M.
    [Show full text]
  • Asymmetric Synthesis of Α-N,N-Dialkylamino Alcohols by Transfer Hydrogenation of N,N-Dialkylamino Ketones
    Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 67 No. 6 pp. 717ñ721, 2010 ISSN 0001-6837 Polish Pharmaceutical Society ASYMMETRIC SYNTHESIS OF α-N,N-DIALKYLAMINO ALCOHOLS BY TRANSFER HYDROGENATION OF N,N-DIALKYLAMINO KETONES TOMASZ KOSMALSKI Department of Organic Chemistry, Collegium Medicum, Nicolaus Copernicus University, M. Curie-Sk≥odowska 9, 85-067, Bydgoszcz, Poland Keywords: β-amino alcohols, Noyori`s catalyst, asymmetric transfer hydrogenation (ATH) β-Amino alcohols are important physiological- instrument. MS spectra were recorded on an AMD ly active compounds (1, 2a,b), also used as ligands 604 spectrometer. Optical rotations were measured (3, 4), and precursors of oxazaborolidines (5). on an Optical Activity PolAAr 3000 automatic Various methods for their asymmetric synthesis, polarimeter. GC analyses were performed on a such as the reduction of α-functionalized ketones Perkin-Elmer Auto System XL chromatograph, with hydrides (6, 7), catalytic hydrogenation of HPLC analyses were performed on a Shimadzu LC- amino ketones (8), reduction with borane/oxaza- 10 AT chromatograph. Melting points were deter- borolidines (9, 10), and other approaches (11ñ13) mined in open glass capillaries and are uncorrected. have been developed. However, the existing meth- Elemental analyses were performed by the ods are not ideal. For example, chiral β-chloro Microanalysis Laboratory, Institute of Organic hydrins, obtained by the reduction of α-chloro Chemistry, Polish Academy of Sciences, Warszawa. ketones, can be transformed into β-amino alcohols Silica gel 60, Merck 230ñ400 mesh was used for by treatment with secondary amines, however, mix- preparative column chromatography. Macherey- tures of isomers are sometimes formed (14). Nagel Polygram Sil G/UV254 0.2 nm plates were Asymmetric transfer hydrogenation (15, 16) used for analytical TLC.
    [Show full text]
  • Phytochemical Profiling of Coryphantha Macromeris
    molecules Article Phytochemical Profiling of Coryphantha macromeris (Cactaceae) Growing in Greenhouse Conditions Using Ultra-High-Performance Liquid Chromatography–Tandem Mass Spectrometry Emmanuel Cabañas-García 1, Carlos Areche 2, Juan Jáuregui-Rincón 1 , Francisco Cruz-Sosa 3,* and Eugenio Pérez-Molphe Balch 1 1 Centro de Ciencias Básicas, Universidad Autónoma de Aguascalientes, Av. Universidad 940, 20131 Aguascalientes, Mexico; [email protected] (E.C.-G.); [email protected] (J.J.-R.); [email protected] (E.P.-M.B.) 2 Departamento de Química, Facultad de Ciencias, Universidad de Chile, Casilla 653, Santiago 7800024, Chile; [email protected] 3 Departamento de Biotecnología, Universidad Autónoma Metropolitana-Iztapalapa. Av. San Rafael Atlixco 186, Col. Vicentina C.P., 09340 Ciudad de México, Mexico * Correspondence: [email protected]; Tel.: +52-555-804-4600 (ext. 2846) Academic Editor: Brendan M Duggan Received: 25 January 2019; Accepted: 14 February 2019; Published: 15 February 2019 Abstract: Chromatographic separation combined with mass spectrometry is a powerful tool for the characterization of plant metabolites because of its high sensitivity and selectivity. In this work, the phytochemical profile of aerial and radicular parts of Coryphantha macromeris (Engelm.) Britton & Rose growing under greenhouse conditions was qualitatively investigated for the first time by means of modern ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC-PDA-HESI-Orbitrap-MS/MS). The UHPLC-PDA-HESI-Orbitrap-MS/MS analysis indicated a high complexity in phenolic metabolites. In our investigation, 69 compounds were detected and 60 of them were identified. Among detected compounds, several phenolic acids, phenolic glycosides, and organic acids were found. Within this diversity, 26 metabolites were exclusively detected in the aerial part, and 19 in the roots.
    [Show full text]
  • EEG and Behavioral Effects in Animals of Some Amphetamine Derivatives with Hallucinogenic Properties
    BEHAVIORAL BIOLOGY, 7, 401-414 (1972), Abstract No. 1-39R EEG and Behavioral Effects in Animals of Some Amphetamine Derivatives with Hallucinogenic Properties V. FLORIO, J. A. FUENTES, H. ZIEGLER and V. G. LONGO Laboratori di Chimica Terapeutica, Istituto Superiore di Sanita, Rome, Italy A study on the central effects of four methoxy-substituted ampheta- mines, of myristicin, and of macromerine has been carried out using rats, rabbits, and cats bearing chronically implanted electrodes. In the rat and in the rabbit the amphetamine derivatives gave rise to a syndrome consisting of a mixture of depression and excitation. Activation of the EEG occurred after small doses of all the drugs, while high doses induced the appearance of spikes and, in some instances, of a grand mal seizure. In the rat, neurovegetative disturbances (vasodilatation) and ejaculation were observed with some of the compounds. Myristicin and macromerine influenced only slightly the EEG and the behavior. The cats, which were trained to an instrumental reward discrimination response, proved to be the most sensitive animal to the effect of these substances. The four amphetamine derivatives, in appropriate dosage, blocked conditioned behavior and caused bizarre behavioral ("hallucinatory") patterns. The behavioral alterations were in- dependent from the modifications of the EEG. A clear-cut EEG activation has been observed only after DOM, while the other derivatives caused a mixed tracing and, with higher doses, synchronization. The correlation between the central activity of these compounds in the various animal species tested in these experiments and their hallucinogenic properties in man indicate that the conditioned cat is the best suited animal for research in this field, since a good relationship exists between the order of potency in disrupting the conditioned response and the human data.
    [Show full text]
  • 誌上発表（原著論文） Summaries of Papers Published in Other Journals（Original Papers）
    ２０６ 国立医薬品食品衛生研究所報告 第１２９号（２０１１） 誌上発表（原著論文） Summaries of Papers Published in Other Journals（Original Papers） Sugiyama, K., Muroi, M., Tanamoto, K., Nishijima, M., response mediator protein-2（CRMP-2 ; 61 kDa）de- Sugita-Konishi, Y. : Deoxynivalenol and nivalenol creased in the late stages of the disease, while the inhibit lipopolysaccharide-induced nitric oxide amount of its truncated form（56 kDa）increased to production by mouse macrophage cells comparable levels observed for the full-length form. Toxicol. Lett., 192, 150-154（2010） Detailed analysis by liquid chromatography-electrospray Deoxynivalenol（DON）and nivalenol（NIV）,tricho- ionization-tandem mass spectrometry showed that the thecene mycotoxins, are secondary metabolites produced 56-kDa form（named CRMP-2-C）lacked the sequence by Fusarium fungi. Trichothecene mycotoxins cause from serine518 to the C-terminus, including the C- immune dysfunction, thus leading to diverse responses terminal phosphorylation sites important for the regula- to infection. The present study evaluated the effect of tion of axonal growth and axon-dendrite specification in DON and NIV on nitric oxide（NO）production by RAW developing neurons. The invariable size of the mRNA 264 cells stimulated with lipopolysaccharide（LPS）. LPS- transcript in Northern blot analysis suggested that the induced NO production was reduced in the presence of truncation was due to post-translational proteolysis. these toxins. The transcriptional activation and expres- By overexpression of CRMP-2-C in primary cultured sion of inducible NO synthase（iNOS）by LPS were also neurons, we observed the augmentation of the develop- repressed by these toxins. DON or NIV inhibited LPS- ment of neurite branch tips to the same levels as for induced expression of interferon-beta（IFN-beta）,which CRMP-2T514A/T555A, a non-phosphorylated mimic of plays an indispensable role in LPS-induced iNOS the full-length protein.
    [Show full text]
  • La Mescaline
    Université de Lille Faculté de Pharmacie de Lille Année Universitaire 2017/2018 THESE POUR LE DIPLOME D'ETAT DE DOCTEUR EN PHARMACIE Soutenue publiquement le 31 octobre 2018 Par M. RIDOUX Florent _____________________________ Description d’une famille d’hallucinogènes : les phényléthylamines psychédéliques, du peyotl aux nouvelles drogues de synthèse _____________________________ Membres du jury : Président : ALLORGE Delphine, Professeur des Universités-Praticien Hospitalier, Faculté de Pharmacie, Université de Lille Assesseur : BORDAGE Simon, Maître de Conférences des Universités, Faculté de Pharmacie, Université de Lille Membre(s) extérieur : DEHEUL Sylvie, Praticien Hospitalier, CEIP-A, CHU de Lille Faculté de Pharmacie de Lille 3, rue du Professeur Laguesse - B.P. 83 - 59006 LILLE CEDEX 03.20.96.40.40 - : 03.20.96.43.64 http://pharmacie.univ-lille2.fr Université de Lille Président : Jean-Christophe CAMART Premier Vice-président : Damien CUNY Vice-présidente Formation : Lynne FRANJIÉ Vice-président Recherche : Lionel MONTAGNE Vice-président Relations Internationales : François-Olivier SEYS Directeur Général des Services : Pierre-Marie ROBERT Directrice Générale des Services Adjointe : Marie-Dominique SAVINA Faculté de Pharmacie Doyen : Bertrand DÉCAUDIN Vice-Doyen et Assesseur à la Recherche : Patricia MELNYK Assesseur aux Relations Internationales : : Philippe CHAVATTE Assesseur à la Vie de la Faculté et aux Relations avec le Monde Professionnel : Thomas MORGENROTH Assesseur à la Pédagogie : Benjamin BERTIN Assesseur à la Scolarité : Christophe BOCHU Responsable des Services : Cyrille PORTA Liste des Professeurs des Universités - Praticiens Hospitaliers Civ. NOM Prénom Laboratoire Mme ALLORGE Delphine Toxicologie M. BROUSSEAU Thierry Biochimie M. DÉCAUDIN Bertrand Pharmacie Galénique M. DEPREUX Patrick ICPAL M. DINE Thierry Pharmacie clinique Mme DUPONT-PRADO Annabelle Hématologie M.
    [Show full text]
  • The Cheillistry of Peyote Al.Kaloids!
    The CheIllistry of Peyote Al.kaloids! GOVIND J. KAPADIA AND M. B. E. FAYEZ Department of Pharmacognosy and Natural Products, College of Pharmacy, Howard University, Washington, D.C. 20001 The fact that several publications, reporting new constituents and biogenetic pathways of peyote, have appeared since the publication of our latest review article (I)-and surely more to come-and the organization of this Symposium all testify that interest in peyote is still far from extinguished. In the lapse of only the past 18 months, fifteen additional constituents of peyote have been reported, bringing the total number of identified constituents of this resourceful cactus to 56 at the time of writing this article. The earliest chemical studies with peyote were made by Lewin (2) in 1888 who isolated the first crystalline constituent, namely the tetrahydroisoqui- noline alkaloid anhalonine (XXXVIII; for structures, cf. table 1). With the realization that the latter compound possessed no hallucinatory effects, vigorous research was continued to discover the active principle. The studies of Heffter (3-8) towards the end of the century resulted in the discovery of three additional tetrahydroisoquinolines, pellotine (XXXV), anhalonidine (XXX), and lophophorine (XLI) and the identification of mescaline (XVII), a il-phene- thylamine, as the hallucinogenic principle of the drug. In 1899, another alkaloid, anhalamine (XXI), was isolated by Kauder (9). Ernst Spath must be ac- credited for the structure elucidation and the synthesis of all these alkaloids, publishing his results in a series of reports from 1919 and extending the scope of his investigations to include alkaloids from other Cactaceae up to 1939 (10-28).
    [Show full text]
  • Sheltering Urban Aboriginal Homeless People Table of Contents
    Sheltering Urban ASSESSMENTAboriginal OF SITUATION Homeless AND NEEDS People In collaboration with The Institute of Urban Studies, University of Winnipeg 1 November 2007 • Prepared by Andrew Webster We really appreciate you coming here and seeing our problems. You say you’ll tell it like it is. We believe you. But why is it they want to hear what some professor guy from Ottawa has to say? We’ve been telling the feds our problems all along. I guess they just don’t write any of it down. Representative of an urban Aboriginal shelter. Sheltering Urban ASSESSMENTAboriginal OF SITUATION Homeless AND NEEDS People Table of Contents Foreword by the Author ..................................................................7 Executive Summary ........................................................................9 Part 1 – Introduction .....................................................................17 Background .........................................................................................................17 Scope of the Project ..............................................................................................17 Methodology .......................................................................................................19 General Approach ................................................................................................ 19 Data Requirements ................................................................................................ 19 Ethical Considerations...........................................................................................
    [Show full text]
  • Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: 1.596 Clinical and Forensic Repercussions
    Send Orders for Reprints to [email protected] 184 Current Molecular Pharmacology, 2019, 12, 184-194 REVIEW ARTICLE ISSN: 1874-4672 eISSN: 1874-4702 Impact Factor: Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: 1.596 Clinical and Forensic Repercussions BENTHAM SCIENCE Ricardo Jorge Dinis-Oliveira1,2,3,*, Carolina Lança Pereira1 and Diana Dias da Silva1,2 1IINFACTS - Institute of Research and Advanced Training in Health Sciences and Technologies, Department of Sci- ences, University Institute of Health Sciences (IUCS), CESPU, Rua Central de Gandra, 1317, 4585-116 Gandra PRD, Portugal; 2UCIBIO/REQUIMTE, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira, 228, Porto, 4050-313, Portugal; 3Department of Public Health and Forensic Sciences, and Medical Education, Faculty of Medicine, Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal Abstract: Background: Mescaline (3,4,5-trimethoxyphenethylamine), mainly found in the Peyote cac- tus (Lophophora williamsii), is one of the oldest known hallucinogenic agents that influence human and animal behavior, but its psychoactive mechanisms remain poorly understood. Objectives: This article aims to fully review pharmacokinetics and pharmacodynamics of mescaline, focusing on the in vivo and in vitro metabolic profile of the drug and its implications for the variability of response. Methods: Mescaline pharmacokinetic and pharmacodynamic aspects were searched in books and in PubMed (U.S. National Library of Medicine) without a limiting period. Biological effects of other compounds found in peyote were also reviewed. A R T I C L E H I S T O R Y Results: Although its illicit administration is less common, in comparison with cocaine and Cannabis, it has been extensively described in adolescents and young adults, and licit consumption often occurs in religious and therapeutic rituals practiced by the Native American Church.
    [Show full text]
  • Biosynthetic Studies on Mescaline and Related Cactus Alkaloids'
    .icu: rtuum. tniecicu 5, 275-J02 (1971) Biosynthetic studies on mescaline and related cactus alkaloids' JAN LUNDSTRoM Ttepurlmeni of Pharmacognosy, Formaceuiiska Fakulieten, Box 680'1, S-11386 Stockholm In this survey, the following papers will be discussed and will be referred to by the Roman numerals given in the following list. Some unpublished results are also presented. L J. Lundstrom and S. Agurell. Thin-layer chromatography of the peyote alkaloids. Journal of Chromatography 30, 271 (1967). II. J. Lundstrom and S. Agurcll. Gas chromatography of peyote alkaloids.A new peyote alkaloid. Journal of Chromatography 36, 105 (1968). Ill. J. Lundstrom and S, Agurell. Synthesis of specifically labelled substituted .8-phenethylamines, Acta Pluirm. Suecica 7,247 (1970), IV, S. Agurell, J. Lundstrom and F. Sandberg.Biosynthesis of mescaline in peyote, Tetrahedron Letlers 2433 (1967). V, J. Lundstrom and S. Agurell, Biosynthesis of mescaline and anhalamine in peyote. Tetrahedron Letters 4437 (1958). VI. S, Agurcll and J, Lundstrom, Apparent intermediates in the biosynthesis of mescaline and related tetrahvdroisoquinolines. Chemical Communica- tions 1638 (1968), 1 Inaugural dissertation. 275 / I J. LUNDSTRo?rf YII. S. Agurell, J. Lundstrom and A. Masoud. Cactaceae alkaloids VII. Alkaloids of Ecliinocereus merkeri. Journal of Pharmaceutical Sciences 58, 1413 (1969). YIII. J. Lundstrom and S. Agurell. Biosynthesis of mescaline and other peyote alkaloids. Abh. d. Deutsch.Akad, Wissenschaften (Berlin). In press. IX. J. Lundstrom and S. Agurell. A complete hiosynthctic sequence from tyrosine to mescaline in two cactus species. Tetrahedron Letters 3371 (1969) . X. J. Lundstrom. Biosynthesis of mescaline and 3,4-dimethoxyphenethyl- amine in Trichocereus pacliatioi Br&R .
    [Show full text]